Apnimed, Inc.
NASDAQ:APMDBiotechnology
Healthcare
$17.45 +2.84%
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Common Stock Repurchased
Cash spent buying back the company's own shares.
No reported Common Stock Repurchased figures are available to summarize.
Common Stock Repurchased history
Currency unavailable · from the cash flow
No Common Stock Repurchased data reported for this period type.
Common Stock Repurchased vs competitors
How APMD compares with its peers on the latest reported figures
APMD Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $100.01M USD | -33.3% | — | 11.1% | |
| LTM Mar 2026 | €0 EUR | — | — | 0.0% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | -33.3% | — | 5.6% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.